RESTORE & TARGET: A CONCEPTUALLY NOVEL TREATMENT APPROACH TO CLASSICAL HODGKIN'S LYMPHOMA

Hematological Oncology - United Kingdom
doi 10.1002/hon.2437_50
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma

Blood Reviews
OncologyHematology
2010English

Lymphocyte-Rich Classical Hodgkin's Lymphoma: Distinctive Tumor and Microenvironment Markers

Modern Pathology
Forensic MedicinePathology
2009English

CD30-targeted Oncolytic Viruses as Novel Therapeutic Approach Against Classical Hodgkin Lymphoma

Oncotarget
Oncology
2018English

Development of Classical Hodgkin's Lymphoma in an Adult With Biallelic STXBP2 Mutations

Haematologica
Hematology
2012English

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

Advances in Hematology
Hematology
2011English

Mocetinostat for Relapsed Classical Hodgkin's Lymphoma: An Open-Label, Single-Arm, Phase 2 Trial

The Lancet Oncology
Oncology
2011English

Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Treatment of Refractory and Relapsed Hodgkin's Lymphoma: Facts and Perspectives

Haematologica
Hematology
2007English

Hodgkin's Lymphoma: A Review of Neurologic Complications

Advances in Hematology
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy